PAA 4.88% 21.5¢ pharmaust limited

Same posters making the same noises they made back just before...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,929 Posts.
    lightbulb Created with Sketch. 1729
    Same posters making the same noises they made back just before the canine cancer option was rejected.
    Roger claiming a deal with BP just around the corner which could be worth $2b, posters stating was a great job Roger was doing and that the sp would be anywhere from $1 to $300.
    Posters also posting how great Roger looked when in facted even back then he was looking jaded.

    Posters howling me down when I suggested that the option would be rejected due to small dog numbers.
    Howled me down when I suggested it was time for Roger to step down.
    Some posters have short memories as now it's MT quoting take over could be worth somewhere between $2.5b and $7b.
    Same posters now going over board in trying to convince themselves that paa could be on a winner this time and trying to shut down anyone who sees things differently.
    Will the FDA give ODD approval well in my opinion its 50 - 50 chance
    Will a BP make any sort of offer, no one knows
    Will PAA phase 2 MND trial be successful well on current data it would appear so but many drugs which have shown great phase 1 results have failed once the trial participants have increased.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
0.010(4.88%)
Mkt cap ! $104.6M
Open High Low Value Volume
20.5¢ 21.5¢ 20.5¢ $244.1K 1.163M

Buyers (Bids)

No. Vol. Price($)
3 71981 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 84173 3
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.